Kidswell Bio News

Kidswell Bio: Confirmation letter

Nov 14 01:50 ET

Kidswell Bio: Half Year Report - 25th Term (2024/04/01 - 2025/03/31)

Nov 14 01:47 ET

Kidswell Bio: Supplementary explanation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025

Nov 12 02:00 ET

Kidswell Bio: Notice regarding consolidated earnings forecasts

Nov 12 02:00 ET

Kidswell Bio: Notice regarding the recording of non-operating income, non-operating expenses, special profit, and extraordinary loss

Nov 12 02:00 ET

Kidswell Bio: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)

Nov 12 02:00 ET

Kidswell Bio: Notice regarding the monthly exercise status of the 4th Unsecured Convertible Bond-Type Stock Acquisition Rights Corporate Bonds and the 15th and 18th Stock Acquisition Rights through Third-Party Allotment

Nov 1 02:30 ET

Kidswell Bio: Notice Concerning Determination of Issuance Details of Stock Compensation Type Stock Options (Stock Acquisition Rights)

Oct 1 04:00 ET

Kidswell Bio: Notice regarding the monthly exercise status of the 4th Unsecured Convertible Bond-Type Stock Acquisition Rights Corporate Bonds and the 15th and 18th Stock Acquisition Rights through Third-Party Allotment

Oct 1 02:30 ET

Kidswell Bio: Announcement of the conclusion of a joint research agreement with Dokkyo Medical University and HOYA Technosurgical Co., Ltd. to develop new treatments for ischemic bone disease

Sep 30 02:00 ET

Kidswell Bio: Notice Concerning Issuance of Stock Options (Stock Acquisition Rights) for Stock Compensation

Sep 12 02:30 ET

Kidswell Bio: Change Report

Sep 5 02:04 ET

Kidswell Bio: Notice regarding the monthly exercise status of the 4th Unsecured Convertible Bond-Type Stock Acquisition Rights Corporate Bonds and the 15th and 18th Stock Acquisition Rights through Third-Party Allotment

Sep 2 02:30 ET

Kidswell Bio: Change Report

Aug 27 02:10 ET

Kidswell Bio: Announcements of individual stocks regarding the recording of non-operating expenses.

Aug 14 02:30 ET

Kidswell Bio: Supplementary explanation material for the first quarter financial results of March 2025 period.

Aug 14 02:30 ET

Kidswell Bio: Financial results for the first quarter ending March 2025 (consolidated) according to Japanese standards.

Aug 14 02:30 ET

Kidswell Bio: Announcements of individual stocks regarding the monthly exercise status of the fourth unsecured convertible bond with stock acquisition rights through third-party allotment and the 15th and 18th subscription rights.

Aug 1 02:30 ET

Kidswell Bio: Change Report

Jul 17 02:02 ET

Kidswell Bio: Announcement of the expiration of the exercise period for the 10th subscription rights (with exercise price adjustment clause).

Jul 10 02:30 ET